Stavanger University Hospital
Stavanger, NO-4011, Norway
NCT Number: NCT01728012
Mineral metabolism disturbances occur early during the course of chronic kidney disease and eventually affect most patients. For how long such disturbances persist after a successful renal transplantation is mainly unknown. This study will investigate the prevalence of such disturbances in patients more than 10 years following a successful renal transplantation. The patients will be recruited from an existing registry in Norway.
Looking for future studies?
Notify Me18 year and older
All sexes
Observational
Stavanger, NO-4011, Norway
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: More than 10 years after successful renal transplantation
To evaluate the long-term effect of a successful renal transplant on this biomarker.
Time frame: More than 10 years after successful renal transplantation
To evaluate the long-term effect of a successful renal transplant on this biomarker.
Time frame: More than 10 years after successful renal transplantation
To evaluate the long-term effect of a successful renal transplant on this biomarker.
Time frame: More than 10 years after successful renal transplantation
To evaluate the long-term effect of a successful renal transplant on this biomarker.
Helse Stavanger HF
Other Gov
The Prevalence of Cardiovascular Risk Factors in Patients More Than 10 Years Following Successful Renal Transplant.
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03016455
Renal Transplant
Amiens, France
View Trial DetailsNCT02894606
Renal Transplant
Brest, France
View Trial DetailsNCT04838288
Renal Transplant
Nashville, Tennessee, United States
View Trial DetailsNCT04572854
C3 Glomerulonephritis, C3 Glomerulopathy
Phoenix, Arizona, United States
View Trial Details